A (Agilent Corp) Total Enterprise Value

Agilent Corp (A) - corporate logo

Agilent Technologies (A) develops high-tech equipment for medical laboratories. The market valuation, driven by the recruitment of leading scientists and R&D personnel, currently stands at 52230.55. The brand's financial stability is underpinned by consistent revenue streams from the sale of services and components. Furthermore, the company is expanding strategic partnerships with forensic experts and pharma behemoths to jointly establish new diagnostic standards.

A Agilent: Enterprise Value in the range 11/23/2025 - 10/28/2026

Agilent Technologies (A) - metric breakdowns and financial figures

- price and consensus price forecast:
Stock Quotes Agilent Technologies, Inc.|A - Analyst Consensus Forecast
- market capitalization data:
Market Value Agilent|A - Enterprise Value
- book capitalization data:
Equity per Share Agilent|A - Book Capitalization|Market Capitalization to Book Value Ratio agilent.com|A - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Ratio Agilent Technologies|A - Long-Term Debt to Capital|Short-Term Debt to Capital agilent.com|A - Company Debts|Debt to Book Capitalization Ratio Agilent|A - Company Long-Term Liabilities|Short-Term Debt Agilent
Analysis of all company metrics:A - Agilent Technologies, Inc.
Original product of Agilent Technologies

The resilience of Agilent Technologies (A) relies on a massive installed base of equipment in the pharmaceutical sector and a steady stream of service payments. The current value of 52230.55 combines market capitalization with net debt, allowing the EV trend to determine the actual acquisition cost of the business, eliminating market illusions and revealing hidden debt loads against the operational efficiency of this industry leader.

Direct competitors

Real Price to Acquire Entire Company Quest Diagnostics Inc. DGX|ILMN (Illumina Corp) - Enterprise Value|EXAS - Total Enterprise Value|Enterprise Value Revvity, Inc.|bio-rad.com (BIO) - Business Value|NNNN (Anbio) - Enterprise Value|Enterprise Value SHC|Total Company Value QuidelOrtho Corp QDEL|Business Value OPKO Health Corp. (OPK)|Enterprise Value CDNA (CareDx Corp)|maravai.com - Enterprise Value|FLGT - Total Company Value|Standard BioTools Inc (LAB) - Total Company Value|Real Price to Acquire Entire Company CTKB|OSUR (OraSure Corp) - Total Enterprise Value|XGN: Total Company Value|Company Buyout Price mdxhealth.com|LUCD (Lucid Diagnostics) - Enterprise Value|Company Buyout Price PRE (prenetics.com)|Total Company Value IMDX|Company Buyout Price Trinity Biotech PLC TRIB|ProPhase Labs, Inc. - Enterprise Value|AIMD - Enterprise Value|Enterprise Value CODX (Co-Diagnostics)|Heart Test Laboratories, Inc. (HSCS) - Full Takeover Company Value|BMRA: Enterprise Value|Company Buyout Price CDIO|Total Company Value Virax Biolabs Group (VRAX)|Total Company Value bluejaydx.com (BJDX)|AWH: Enterprise Value|Accelerate Diagnostics Inc. - Total Enterprise Value|Centogene (CNTG) - Total Company Value|Enzo Biochem, Inc. (ENZ) - Business Value|FRES - Real Price to Acquire Entire Company|Aggregate Business Value Genetic Technologies Limited|ME - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Psychemedics Corp. (PMD)